Company
Sydnexis
Closing the Critical Innovation Gap in Pediatric Progressive Myopia
Also known as Sydnexis, Inc.
- Status
- Operatingas of 2026-09-17
- Headquarters
- San Diego, California, United States
- Founded
- 2014
- Legal name
- Sydnexis, Inc.
- sydnexis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Pediatric progressive myopia (PPM) is the leading cause of vision loss in children, with risks that extend far beyond the need for glasses, which address symptoms but do not treat the underlying disease. Yet treatment options remain limited — especially for younger children. At Sydnexis, we are focusing on a critical gap in care. We aim to advance innovation that can not only help preserve vision in growing eyes but may offer a new path forward for children and their families.
Funding snapshot
- Total raised
- $72.3MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $20M2025-04-03
Funding rounds
- Round, 2025
- $20M2025-04-03, SEC form D sold, 23 investors
- Round, 2024
- $1000K2024-04-24, SEC form D sold, 30 investors
- Round, 2021
- $45.8M2021-08-06, SEC form D sold, 26 investors
- Round, 2017
- $5.5M2017-10-06, SEC form D sold, 6 investors
Products
- Other
- SYD-101
Loading relationship preview